RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA)

Historical Holders from Q2 2020 to Q2 2025

Symbol
DNA on NYSE
CUSIP
37611X100
Type / Class
Equity / Common Stock
Shares outstanding
383M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 6.5% -30% $5.72M -$126K 24.9M -1.49% BAILLIE GIFFORD & CO Dec 31, 2024

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$203K 0
2025 Q1 607K $203K +$203K $0.33 1
2024 Q4 0 $0 -$129K 0
2024 Q3 18.9K $125K -$302M $0.33 6
2024 Q2 933M $311M -$135M $0.33 305
2024 Q1 1.28B $1.48B +$9.02M $1.16 326
2023 Q4 12.8M $21.7M +$3.3M $1.69 4
2023 Q3 1.22B $2.2B +$42.6M $1.81 337
2023 Q2 1.14B $2.12B +$141M $1.86 300
2023 Q1 1.13B $1.5B +$187M $1.33 302
2022 Q4 990M $1.67B +$183M $1.69 306
2022 Q3 874M $2.73B +$302M $3.12 249
2022 Q2 697M $1.66B +$215M $2.38 239
2022 Q1 665M $2.67B -$1.02B $4.03 178
2021 Q4 897M $7.38B +$845M $8.31 153
2021 Q3 792M $9.18B +$9.18B $11.59 122
2020 Q2 15K $36K $0 $2.40 1